NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Bellus Health INC


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
BELLUS Health Inc. Announces $12 Million Rights Offering To Common Shareholders
2009 JUL 20 ... BELLUS Health Inc. (TSX: BLU) announced that it is filing a preliminary short form prospectus in each of ...
Subject: Pharmaceuticals
Price: $3.00
*
BELLUS Health inc. announces completion of first tranche of financing
2009 APR 28 ... Further to the press releases of March 31 and April 8, 2009, BELLUS Health Inc. ("BELLUS Health") (TSX: BLU) is pleased to announce the completion of the first ...
Subject: Bellus Health INC.
Price: $3.00
*
BELLUS Health reports results for first half of fiscal 2009
2009 AUG 25 ... BELLUS Health Inc. ("BELLUS Health" or the "Company") (TSX: BLU) reported results for the second ...
Subject: Bellus Health INC.
Price: $3.00
*
BELLUS Health reports results for first quarter of fiscal 2009
2009 MAY 18 ... BELLUS Health Inc. ("BELLUS Health" or the "Company") (TSX: BLU) reported results for the ...
Subject: Bellus Health INC.
Price: $3.00
*
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BELLUS Health Inc.
2009 JAN 26 ... LLC announced that it has issued an Executive Informational Overview(R) (EIO(R)) on BELLUS Health Inc. (BLU: TSX). The full 52-page report can be found at www.crystalra.com. ...
Subject: Crystal Research Associates, Llc
Price: $3.00
*
Gentium Announces New Board of Directors and Interim CEO
2009 NOV 23 ... shareholders: Dr. Francesco Bellini - Chairman, President and Chief Executive Officer of Bellus Health Inc., a global company focused on the development and commercialization of healthcare ...
Subject: Gentium S.p.A.
Price: $3.00
*
New Alzheimer disease study findings recently were reported by S. Gauthier and co-researchers
2009 AUG 24 ... & Aging, 2009;13(6):550-557). For more information, contact D. Saumier, BELLUS Health Inc., 275 Boul Armand Frappier, Laval, PQ H7V 4A7, Canada. Publisher contact ...
Subject: Alzheimer Disease
Price: $3.00
*
VIVIMIND(TM) granted certificate of free sale as food supplement in Italy - Premarket notification filed in the U.S.
2009 JUL 27 ... BELLUS Health (International) Limited, a wholly owned subsidiary of BELLUS Health Inc. (BELLUS Health, TSX: BLU), announced that the Italian Ministry of Health has granted a ...
Subject: Bellus Health INC.
Price: $3.00
*
BELLUS Health announces closing of Innodia acquisition
2008 JUL 28 ... BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU, formerly known as Neurochem Inc.) announced the closing of the ...
Subject: Obesity and Diabetes
Price: $3.00
*
BELLUS Health announces formal notice to voluntarily delist from NASDAQ
2008 DEC 30 ... BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU) announces that it has provided formal notice to the NASDAQ ...
Subject: Bellus Health INC.
Price: $3.00
*
BELLUS Health Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
2008 NOV 25 ... BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU) announces that it has received approval from the NASDAQ ...
Subject: Bellus Health Inc.
Price: $3.00
*
BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capital Market
2008 DEC 16 ... BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU) announces that in light of continuing significant fluctuations ...
Subject: Bellus Health INC.
Price: $3.00
*
BELLUS Health moves forward on nutraceutical and pharmaceutical fronts - Reports Results for First Half of 2008
2008 AUG 18 ... BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU) announced meaningful progress in both its nutraceutical and ...
Subject: Obesity and Diabetes
Price: $3.00
*
BELLUS Health provides update on activities
2008 NOV 3 ... BELLUS Health Inc. (NASDAQ: BLUS; TSX:=C2=A0BLU) is pleased to provide an update on its branded ...
Subject: Bellus Health Inc.
Price: $3.00
*
BELLUS Health Receives Nasdaq Deficiency Notice Relating to Market Value
2008 OCT 28 ... BELLUS Health Inc. (NASDAQ: BLUS; TSX:=C2=A0BLU) announces that it received a Nasdaq Staff Deficiency ...
Subject: Bellus Health Inc.
Price: $3.00
*
BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update
2008 NOV 24 ... BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU) reports results for the third quarter ended September 30, ...
Subject: Bellus Health Inc.
Price: $3.00
*
BELLUS Health signs agreement to acquire Innodia
2008 JUL 28 ... BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU, formerly known as Neurochem Inc.) announced that it has signed ...
Subject: Obesity and Diabetes
Price: $3.00
*
BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference
2008 NOV 18 ... BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU) announces that on Tuesday, November 11, Mr. Gary Schmid, ...
Subject: Bellus Health Inc.
Price: $3.00
*
VIVIMIND(TM), Canada's scientifically proven natural health product to protect memory function, is available starting today
2008 SEP 15 ... OVOS Natural Health Inc., a wholly owned subsidiary of BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU), announces that VIVIMIND(TM), the company's first natural ...
Subject: Aging
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login